Skip to main content
CARE Ratings Limited logo

CARE Ratings Limited — Investor Relations & Filings

Ticker · CARERATING ISIN · INE752H01013 LEI · 335800BPDT71YUVM2E79 BSE.NS Financial and insurance activities
Open in API
Filings indexed 1,127 across all filing types
Latest filing 2025-11-12 Investor Presentation
Country IN India
Listing BSE.NS CARERATING

About CARE Ratings Limited

https://www.careratings.com

CARE Ratings Limited provides comprehensive credit rating services designed to facilitate informed investment decisions through the assessment of credit risk. The organization offers ratings for a diverse array of debt instruments, including bank loans, debentures, commercial paper, and bonds. Its service portfolio encompasses corporate governance ratings, ESG assessments, and specialized research services. Serving a broad clientele across sectors such as manufacturing, infrastructure, and financial services, the entity utilizes rigorous analytical frameworks and methodologies to evaluate creditworthiness. The company also provides ratings for small and medium enterprises and offers risk management solutions. By delivering independent and objective evaluations, the firm supports capital market transparency and enhances the efficiency of credit allocation processes.

Recent filings

Filing Released Lang Actions
Press Release
Investor Presentation Classification · 91% confidence The document is a combined press release and investor deck filed under SEBI Regulation 30. It contains detailed slides on macroeconomics, business segments, financial results for Q2 and H1 FY26, strategic outlook, and corporate presentations. This matches the definition of an Investor Presentation (IP) rather than a simple earnings release or regulatory notice.
2025-11-12 English
Appointment
Regulatory Filings Classification · 82% confidence The document is a formal notice under SEBI Listing Regulations (Regulation 30), titled “Outcome of the meeting of the Board of Directors,” sent to BSE and NSE. It discloses multiple regulatory updates—quarterly unaudited financial results, interim dividend declaration, appointment of an additional director, ESOP grant, and partial stake sale. It is not itself the full financial or audit report (it attaches results), nor is it solely an AGM presentation, earnings press release, or management discussion. This multi‐item listing disclosure does not fit cleanly into specific categories like MANG (which covers only board changes) or ER (earnings release). Therefore it is best classified as a general regulatory filing under “Regulatory Filings” (RNS).
2025-11-12 English
Dividend
Interim / Quarterly Report Classification · 60% confidence The document is a board meeting outcome notification filed under SEBI LODR, but crucially it includes the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, along with the auditors’ Limited Review Report (and extends to over 300,000 characters, indicating the full tables and notes are embedded). Under our taxonomy, a comprehensive half-year/quarter financial report containing substantive data and analysis qualifies as an Interim/Quarterly Report (IR). Although the notice also covers dividends, a director appointment, ESOP grants, and a stake sale, the presence of the full financial statements and review report places it squarely in the IR category rather than a simple regulatory announcement. H1 2025
2025-11-12 English
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is a composite ‘‘Outcome of Board Meeting’’ notice filed under SEBI LODR Regulation 30 to BSE and NSE. It discloses multiple items – approval of unaudited quarterly/half‐yearly financial results (with a limited review report attached), declaration of an interim dividend, an independent director appointment, ESOP grants and a sale of subsidiary stake. It is a regulatory announcement of board decisions to the exchanges rather than the standalone financial report itself (the results are ‘‘enclosed’’), and it covers a variety of compliance topics that do not fit any single narrow category. As such, it falls under the general Regulatory Filings (RNS) category.
2025-11-12 English
Record Date
Regulatory Filings Classification · 90% confidence The document is a regulatory disclosure under SEBI LODR Regulation 30 notifying stock exchanges of the outcome of a Board meeting (approval of unaudited Q2/half-year financial results, interim dividend, director appointment, ESOP grant, and sale of subsidiary stake). It does not itself contain full financial statements but rather announces multiple items of material information in one composite filing. This falls under the general “Regulatory Filings” category (RNS) as a miscellaneous compliance announcement.
2025-11-12 English
Dividend
Regulatory Filings Classification · 85% confidence The document is an “Outcome of Board Meeting” notice filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It does not itself contain detailed financial statements but states that the Unaudited Financial Results and Limited Review Report are enclosed, declares an interim dividend, appoints a director, grants ESOPs, and notes a partial stake sale. This is a multi‐item regulatory disclosure rather than the report itself or any singular event‐specific filing. Therefore it falls into the general regulatory announcements/fallback category (RNS).
2025-11-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.